To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·10-08 07:13
      ARKG Investment Tracker position change: Increased position in Alamar Biosciences by 22,534 shares, the number of shares held increased 2.26% compared to the previous period and now represents 1.6% of the total position.
      8Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·10-08 07:13
      ARKG Investment Tracker position change: Increased position in Freenome, Inc. by 64,070 shares, the number of shares held increased 8.51% compared to the previous period and now represents 0.56% of the total position.
      50Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·10-08 07:13
      ARKG Investment Tracker position change: Increased position in CareDx by 12,176 shares, the number of shares held increased 0.8% compared to the previous period and now represents 4.41% of the total position.
      8Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·10-08 07:13
      ARKG Investment Tracker position change: Increased position in Adaptive Biotechnologies Corp by 41,781 shares, the number of shares held increased 2.26% compared to the previous period and now represents 2.32% of the total position.
      36Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·10-08 07:13
      ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 250,268 shares, the number of shares held increased 2.26% compared to the previous period and now represents 1.34% of the total position.
      411Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·10-08 07:13
      ARKG Investment Tracker position change: Increased position in Veracyte by 139,640 shares, the number of shares held increased 13.03% compared to the previous period and now represents 2.37% of the total position.
      10Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·10-08 07:13
      ARKG Investment Tracker position change: Increased position in Nurix Therapeutics by 39,596 shares, the number of shares held increased 2.26% compared to the previous period and now represents 1.68% of the total position.
      3Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·10-08 07:13
      ARKG Investment Tracker position change: Increased position in CRISPR Therapeutics AG by 48,849 shares, the number of shares held increased 2.26% compared to the previous period and now represents 5.21% of the total position.
      90Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·10-08 07:13
      ARKG Investment Tracker position change: Increased position in Guardant Health Inc. by 13,319 shares, the number of shares held increased 2.25% compared to the previous period and now represents 4.64% of the total position.
      50Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·10-08 07:13
      ARKG Investment Tracker position change: Increased position in Butterfly Network Inc by 112,309 shares, the number of shares held increased 2.26% compared to the previous period and now represents 1.96% of the total position.
      38Comment
      Report
       
       
       
       

      Most Discussed